http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004067024-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae7c9a3de4e1144ef0cef96563276ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91f4d31f1709093691b3714d189152e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eaad1255f05a8d6e6d8a2332257fcb58
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
filingDate 2004-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6fccd0ddab2dde2ff943afd4d791086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1af23fc716737de63d2c23591dc91bc6
publicationDate 2004-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004067024-A2
titleOfInvention Hcv combination therapy
abstract A peptide which has at least 80% identity to a fragment of Domain A or B of the Hepreceptor of ezrin, is used with an interferon as a combined preparation for simultaneous, separate or sequential use in the treatment of viral hepatitis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021198346-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016193285-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2694906-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022207818-A1
priorityDate 2003-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6001799-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0125275-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0707855-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588349
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31977
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID561589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408914
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7430
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54319
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497144
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395701
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26040
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408915
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8HZQ5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_003370
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A7D9NK43
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1SB42
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15311
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281574
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9YGW6
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11103

Total number of triples: 56.